BACTERIA IN CANCER THERAPY: AN EMERGING ROBUST STRATEGY 

Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2013, Vol 4, Issue 5

Abstract

 Cancer is one of the leading causes of death in the world. Solid tumors account for 90% of all cancers. Despite rapid developments in the conventional modalities of cancer treatment (chemotherapy and radiotherapy) there is still no definitive “cure” for cancer. The present observation aims to an eye on alternative cancer therapies. The search for alternative therapies dates back to early 1800’s when a patient was observed to recover spontaneously following an infection. This resulted in the birth of Coley’s toxin for the treatment of sarcomas and use of live Bacillus Calmette – Guerin (BCG) for bladder cancer. The same provoked for a series of researches in this field, but was heralded due to lack of specificity, lack of complete tumor lyses and ineffectiveness against small tumors. However with the advent of recombinant DNA technology and its developments, it has paved the way for a new era for a tumor- targeted bacterial vector system for gene therapy of solid tumors. In this review we will discuss the potential of genetically manipulated bacteria that will usher in the new era of bacterial therapy for solid tumors.

Authors and Affiliations

Preenu Sen, Gautham A, Murugan Manavalan, Ani Mansoor

Keywords

Related Articles

FORMULATION AND EVALUATION OF NOVEL ANTI-BACTERIAL CIPROFLOXACIN LOADED NIOSOMAL CREAM  

The development of Ciprofloxacin loaded niosomes using combination of Span-60 and Lipotin A, to increase the local effect of Ciprofloxacin on the bacterial infected skin. Ciprofloxacin encapsulated niosomes were formulat...

CYCLODEXTRINS: AN EXCIPIENT TOOL IN DRUG DELIVERY 

Cyclodextrins (CDs) are a family of compounds consist of glucose monomers arranged in a donut shape ring. They are non-reducing, crystalline cyclic oligosaccharides which proximate a truncated core generating a hydrophil...

COMPARATIVE STUDY ON THE SUBSTITUTES USED IN AYURVEDA WITH SPECIAL REFERENCE TO SUBSTITUTES FOR PUSHKARAMULA (INULA RACEMOSA HOOK.F.) VIZ., KUSHTA (SAUSSUREA LAPPA DECNE.) AND ERANDAMULA (RICINUS COMMUNIS L.): A CLINICAL STUDY  

Ayurvedic literature introduced several substitutes for the herbs which are either not available or which are not accessible for various reasons. On review of more than 35 texts and their commentaries it is found that th...

SCREENING OF PHYCOCHEMICAL CONSTITUENTS QUALITATIVELY AND QUANTITATIVELY CERTAIN SEAWEEDS FROM GULF OF MANNAR BIOSPHERE RESERVE  

The six seaweeds namely Ulva lactuca (L), Caulerpa racemosa C. Agardh, Sargassum wightii Greville, Padina tetrastomatica Hauck, Gracilaria corticata var. cylindrica J. Ag., and Acanthophora spicifera (vahl.) Boergesen, c...

NEW PHENOLIC ACIDS FROM THE GALLS OF TAMARIX APHYLLA (L.) KARST. 

Phytochemical investigation of the galls of Tamarix aphylla (L.) Karst., syn. T. articulata Vahl. (Tamaricaceae) led to the isolation of three new phenolic acids identified as 3, 5- dihydroxy- 4 - (4’-hydroxybenzoxy) ben...

Download PDF file
  • EP ID EP135810
  • DOI 10.7897/2230-8407.04501
  • Views 80
  • Downloads 0

How To Cite

Preenu Sen, Gautham A, Murugan Manavalan, Ani Mansoor (2013). BACTERIA IN CANCER THERAPY: AN EMERGING ROBUST STRATEGY . International Research Journal of Pharmacy (IRJP), 4(5), 1-4. https://europub.co.uk/articles/-A-135810